On Monday, Novo Nordisk started distributing a tablet form of its shot-based weight management medication Wegovy across the United States. For individuals paying out-of-pocket, the initial monthly cost begins at $149. Those covered by insurance plans can access the medication for a minimum of $25 monthly.
This once-daily tablet arrives in a thriving market for obesity and diabetes treatments, where expensive weekly shots from Novo Nordisk and Eli Lilly have previously held sway. Listing it on Amazon highlights Novo Nordisk's approach to broaden distribution methods and attract additional users.
According to Amazon, insured eligible buyers can acquire a one-month dose for no more than $25. The self-pay alternative kicks off at $149 monthly.
